About
Our Company
RidNova Pharmaceuticals offers end-to-end pharmaceutical product development, manufacturing and commercialisation solutions, specialising in B2B services for global regulatory markets, including the EU, USA, MENA, CIS, LATAM and Canada.
We focus on key therapeutic areas, including Oncology, Cardiovascular diseases, Metabolic disorders (Diabetes, Obesity, Cystic Fibrosis and Thyroid disorders), Gastroenterology, Neurology, Respiratory, Immunology, Dermatology and Rare diseases.
As a trusted partner for complex drug product development, we provide innovative and cost-effective pharmaceutical solutions from proof-of-concept to market launch, ensuring adherence to the highest standards of international regulatory compliance.
Leveraging cutting-edge technologies, expertise in advanced R&D, and a focus on therapeutic innovation enables us to streamline drug development, accelerate time-to-market, and achieve therapeutic advancement and biopharmaceutical excellence.
Our commitment to quality, innovation and regulatory compliance positions RidNova as a reliable partner in meeting the unmet needs of patients worldwide.
Our Team
Dr. Devendra Ridhurkar
Founder & CEOVision & Mission
Our Vision
To transform global healthcare through pharmaceutical advancement, foster strategic collaborations and ensure affordable, sustainable, and impactful healthcare solutions that enhance human life.
Our Mission
To deliver innovative and sustainable pharmaceutical solutions that address complex health challenges by leveraging cutting-edge technologies, expertise and excellence to meet the unmet needs of patients and healthcare systems worldwide.
